Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: pyridostigmine
What it is used for
INDICATIONS AS AT 3 AUGUST 1992: Mestinon is useful in the treatment of myasthenia gravis.
How to take it
- The way to take this medicine: Oral
- Store below 30 degrees Celsius
- Shelf lifetime is 24 Months.
Always read the label. If symptoms persist see your healthcare professional.
Cylindrical, biconvex, white - almost white tablet. no imprint.
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine contains the active ingredients:
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Pregnant or planning a pregnancy?
For the active ingredient pyridostigmine
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Mestinon Tablets - myDr.com.au
Mestinon Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Myasthenia gravis - myDr.com.au
Myasthenia gravis is a chronic muscle disease that produces weakness and abnormally rapid fatigue of the voluntary muscles.
Read more on myDr website